PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Interstitial Lung Disease and Rheumatology Unit, Instituto Nacional de Enfermedades Respiratorias \'Ismael Cosío Villegas\', Mexico City, Mexico.\', \'Otolaryngology Department, Instituto Nacional de Enfermedades Respiratorias \'Ismael Cosío Villegas\', Mexico City, Mexico.\', \'Department of Investigation on Tobacco and Chronic Obstructive Pulmonary Disease, Instituto Nacional de Enfermedades Respiratorias \'Ismael Cosío Villegas\', Mexico City, Mexico.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0261980
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 35139097
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • Hydroxychloroquine for prophylaxis of COVID-19 in health workers: A randomized clinical trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all